Plasma fatty acids depletion: a metabolic signature related to colon cancer
Ontology highlight
ABSTRACT: Understanding the complex interplay between tumor biology and host metabolism presents a formidable challenge with important clinical implications. At the local level, metabolic alterations of tumor cells and tumor microenvironment is a well-recognized process and constitute one of the major hallmarks of cancer cells. Consequently, research has largely isolated tumor biology from systemic metabolic dynamics, overlooking their potential interrelation. Nonetheless, cancer pathology is also very clearly associated with broad systemic metabolic disturbances, as exemplified by the frequent development of cachexia, which reaches up to 40% of colon cancer (CC) patients. Other metabolic alterations observed associated with cancer include insulin resistance, hypercalcemia, and amino acid metabolism, which underline the extensive systemic impact of cancer on the metabolic networks. In addition to these alterations, another interesting yet less studied phenomenon in cancer pathology is the observation that cancer patients present alterations of their typical fatty acid profiles in circulation. Evidence of this phenomenon is limited and scattered across the literature, although some studies have identified this alteration in patients with colorectal and liver cancer. Nonetheless, discerning whether these lipid profile shifts signify an intrinsic metabolic alteration or are secondary to factors such as malnutrition, adipose tissue dynamics, or clinical parameters like tumor staging and location has yet to be determined. It is evident that addressing this issue requires a more comprehensive analysis of the possible factors involved. Our study adopted an integrative methodology to study this process in CC, combining advanced body composition analysis, nutritional assessments, extensive clinical and transcriptomic data of the tumor, and precise profiling of esterified fatty acids in plasma. This multifaceted strategy has enabled us to confirm that the alteration of FA levels is a frequent phenomenon in patients with CC.
ORGANISM(S): Homo sapiens
PROVIDER: GSE267846 | GEO | 2025/05/28
REPOSITORIES: GEO
ACCESS DATA